On March 19, 2025, SWK Holdings Corp agreed to sell its royalty rights for about $34 million and plans to use part of the proceeds for a cash dividend to shareholders. Additionally, on March 17, 2025, ANI Pharmaceuticals notified SWK of its intent to buy back certain royalties, generating approximately $17.3 million for the company.